Skip to main content
. 2014 Feb 13;10(2):e1004135. doi: 10.1371/journal.pgen.1004135

Figure 7. Anti-tumor activity in Patient 4 harboring an FGFR2-MGEA5 fusion, to FGFR inhibitors.

Figure 7

A) CT images of patient 4, whose tumor possessed an FGFR2-MGEA5 fusion, at baseline and 6 weeks demonstrate central necrosis of a caudate liver lobe mass (left arrow), 2.6 cm at baseline and 6 weeks, and shrinkage of a metastatic supraceliac axis lymph node (right arrow), 3.1 cm and 2.9 cm at baseline and 6 weeks respectively. B) CT images of patient 4 showing shrinkage of metastatic lymph nodes involving the right cardiophrenic angle (red circles), 1.3 cm and 0.5 cm at baseline and 6 weeks respectively.